Media

Our latest news and articles

10 things we’ve learned in 10 years of biologics at CPI
Blog

10 things we’ve learned in 10 years of biologics at CPI 

Celebrating 10 years of Biologics at CPI: a decade of innovation, collaboration, and growth shaping the future of UK biologic medicines. 

Oct 13 2025
CPI Enterprises portfolio updates – H1 2025
Blog

CPI Enterprises portfolio updates – H1 2025 

What updates, successes, and funding did our CPI Enterprises portfolio companies have in the first half of 2025? Tom Hillier details all. 

Oct 06 2025
Innovative UK-Brazil-Nigeria partnership to revolutionise cassava farming in Nigeria
News

Innovative UK-Brazil-Nigeria partnership to revolutionise cassava farming in Nigeria 

Led by CPI, the new partnership is set to transform cassava farming in Nigeria through innovation, knowledge-sharing, and support for smallholder farmers. 

Sept 30 2025
From trains to strains: A two-century journey of innovation in Darlington
Blog

From trains to strains: A two-century journey of innovation in Darlington 

2025 marks 200 years of rail and 10 years of CPI’s National Biologics Manufacturing Centre in Darlington, from steam locomotives to RNA medicines. 

Sept 25 2025
MedTech industry innovators and investors call for urgent action to unblock UK MedTech bottlenecks
News

MedTech industry innovators and investors call for urgent action to unblock UK MedTech bottlenecks 

Three CPI reports reveal barriers facing UK MedTech startups and spinouts, calling for reform in regulation, investment and NHS adoption to unlock growth. 

Sept 18 2025
Four UK innovators selected to transform patient flow through 5G-enabled healthcare solutions
News

Four UK innovators selected to transform patient flow through 5G-enabled healthcare solutions 

CPI’s 5G innovation programme to accelerate digital solutions in healthcare has now selected four companies to receive tailored support from CPI. 

Sept 04 2025
CPI and Quotient Sciences to accelerate RNA drug development with joint venture
News

CPI and Quotient Sciences to accelerate RNA drug development with joint venture 

CPI and Quotient Sciences have signed an MoU to form a joint venture aimed at accelerating the development of RNA-based therapies. 

Sept 02 2025
Government-backed UK RNA Biofoundry to turbo-charge next-gen therapies through CPI's RNA Centre of Excellence
News

Government-backed UK RNA Biofoundry to turbo-charge next-gen therapies through CPI’s RNA Centre of Excellence 

Backed by £29.6m government funding, the UK RNA Biofoundry will drive new RNA therapies – helping tackle cancer, heart conditions, and other diseases. 

Aug 28 2025
New partnership to advance RNA vaccines for livestock
News

New partnership to advance RNA vaccines for livestock 

CPI and CVIM sign MoU to boost veterinary vaccine development, starting with cutting-edge RNA vaccine technologies at The Pirbright Institute. 

Aug 06 2025
 Previous Next  
1 2 3 4 Next  

Page 2 of 103

CPI is your innovation partner to make your ideas a reality.